- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech High Insider Buying
Hong Kong Pharmaceuticals & Biotech High Insider Buying
Results
21
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
21 companies
Sino Biopharmaceutical
Market Cap: HK$85.2b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$4.69
7D
3.3%
1Y
-6.2%
CSPC Pharmaceutical Group
Market Cap: HK$84.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$7.08
7D
1.1%
1Y
-13.6%
3SBio
Market Cap: HK$42.8b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$16.48
7D
6.9%
1Y
-22.6%
Shanghai Junshi Biosciences
Market Cap: HK$31.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
1877
HK$16.51
7D
2.3%
1Y
-29.7%
Simcere Pharmaceutical Group
Market Cap: HK$26.0b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$9.94
7D
3.8%
1Y
-7.4%
Grand Pharmaceutical Group
Market Cap: HK$17.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$4.95
7D
-1.0%
1Y
-44.8%
Duality Biotherapeutics
Market Cap: HK$17.0b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$181.60
7D
4.1%
1Y
-26.4%
Everest Medicines
Market Cap: HK$9.5b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$26.30
7D
-4.4%
1Y
-47.9%
HBM Holdings
Market Cap: HK$9.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$10.12
7D
6.2%
1Y
30.4%
CStone Pharmaceuticals
Market Cap: HK$7.7b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$4.73
7D
10.0%
1Y
14.3%
CF PharmTech
Market Cap: HK$7.5b
Engages in research and development, production, and sale of respiratory drugs and other related medical products in China.
2652
HK$17.91
7D
-6.0%
1Y
n/a
Shanghai Haohai Biological Technology
Market Cap: HK$7.5b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$16.56
7D
-3.0%
1Y
-35.7%
Shanghai Bao Pharmaceuticals
Market Cap: HK$6.3b
A biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China.
2659
HK$18.41
7D
-2.9%
1Y
n/a
Antengene
Market Cap: HK$2.4b
A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.
6996
HK$3.30
7D
-2.1%
1Y
-4.9%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$1.7b
A biotechnology company, engages in the research and development of immuno-oncology therapies in China and the United States.
1541
HK$3.64
7D
18.2%
1Y
-70.8%
Kintor Pharmaceutical
Market Cap: HK$1.2b
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$2.35
7D
-2.9%
1Y
46.9%
Lee's Pharmaceutical Holdings
Market Cap: HK$618.3m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.05
7D
-1.9%
1Y
-30.5%
Transcenta Holding
Market Cap: HK$597.3m
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$1.49
7D
10.4%
1Y
-3.9%
Sirnaomics
Market Cap: HK$510.7m
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of China.
2257
HK$4.78
7D
0%
1Y
22.9%
China NT Pharma Group
Market Cap: HK$431.8m
An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$0.46
7D
5.8%
1Y
3.4%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$416.8m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$2.88
7D
-3.4%
1Y
396.6%